Home > Insider Trading > Filing (0001209191-10-048672)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1333248	Cadence Pharmaceuticals Inc	CADX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1378690	R Theodore Schroeder	C/O Cadence Pharmaceuticals, Inc. 12481 High Bluff Drive, Suite 200 San Diego CA 92130	President, Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-09-30	40,703	$8.35	320,297	No	4	S	Indirect	By the Schroeder Living Trust
Common Stock	Disposition	2010-10-01	9,297	$8.35	311,000	No	4	S	Indirect	By the Schroeder Living Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By the Schroeder Living Trust
No	4	S	Indirect	By the Schroeder Living Trust

Footnotes

The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2009.
This transaction was executed in multiple trades at prices ranging from a low of $8.25 to a high of $8.51. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Mr. Schroeder is the trustee of this trust.
This transaction was executed in multiple trades at prices ranging from a low of $8.30 to a high of $8.47. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.